These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 26310004)

  • 41. Efficacy of 12-month treatment of neovascular age-related macular degeneration with intravitreal bevacizumab based on individually determined injection strategies after three consecutive monthly injections.
    Mekjavic PJ; Kraut A; Urbancic M; Lenassi E; Hawlina M
    Acta Ophthalmol; 2011 Nov; 89(7):647-53. PubMed ID: 19860774
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glaucoma Tube Outcomes with and without Anti-VEGF in Patients with Age-related Macular Degeneration.
    Rothman AL; Beca FA; Tijerina JD; Schuman DM; Parrish RK; Vanner EA; Liu KC
    Ophthalmol Glaucoma; 2024; 7(3):260-270. PubMed ID: 38266962
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-VEGF response in macular hemorrhage and incidence of retinal pigment epithelial tears.
    Varshney N; Jain A; Chan V; Yu L; Sarraf D
    Can J Ophthalmol; 2013 Jun; 48(3):210-5. PubMed ID: 23769784
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical predictors of sustained intraocular pressure elevation due to intravitreal anti-vascular endothelial growth factor therapy.
    Hoang QV; Tsuang AJ; Gelman R; Mendonca LS; Della Torre KE; Jung JJ; Freund KB
    Retina; 2013 Jan; 33(1):179-87. PubMed ID: 22990314
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in Fundus Autofluorescence after Anti-vascular Endothelial Growth Factor According to the Type of Choroidal Neovascularization in Age-related Macular Degeneration.
    Lee JY; Chung H; Kim HC
    Korean J Ophthalmol; 2016 Feb; 30(1):17-24. PubMed ID: 26865799
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bevacizumab for neovascular age-related macular degeneration in China.
    Li X; Hu Y; Sun X; Zhang J; Zhang M;
    Ophthalmology; 2012 Oct; 119(10):2087-93. PubMed ID: 22818896
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravitreal anti-vascular endothelial growth factor for typical exudative age-related macular degeneration in eyes with good baseline visual acuity.
    Chang YS; Han JI; Yoo SJ; Lew YJ; Kim JH
    Korean J Ophthalmol; 2014 Dec; 28(6):466-72. PubMed ID: 25435749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circulating anti-retinal antibodies in response to anti-angiogenic therapy in exudative age-related macular degeneration.
    Kubicka-Trząska A; Wilańska J; Romanowska-Dixon B; Sanak M
    Acta Ophthalmol; 2014 Dec; 92(8):e610-4. PubMed ID: 24802549
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravitreal ranibizumab injection for neovascular age-related macular degeneration in phakic versus pseudophakic eyes.
    Baek JS; Cho HJ; Cho SW; Kim CG; Kim JW
    Retina; 2013 Mar; 33(3):467-73. PubMed ID: 23400082
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Intraocular pressure and ocular blood flow features intravitreal infection of anti-vascular endothelial growth factor agents].
    Mamikonian VR; Galoian NS; Budzinskaia MV; Kazarian ÉÉ; Sdobnikova SV; Shmeleva-Demir OA; Rafaeian AA; Ryzhkova EG
    Vestn Oftalmol; 2014; 130(5):16-21. PubMed ID: 25711057
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Morphologic parameters relevant for visual outcome during anti-angiogenic therapy of neovascular age-related macular degeneration.
    Simader C; Ritter M; Bolz M; Deák GG; Mayr-Sponer U; Golbaz I; Kundi M; Schmidt-Erfurth UM
    Ophthalmology; 2014 Jun; 121(6):1237-45. PubMed ID: 24684838
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration.
    Schmidt-Erfurth U; Waldstein SM; Deak GG; Kundi M; Simader C
    Ophthalmology; 2015 Apr; 122(4):822-32. PubMed ID: 25578255
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Short-term intraocular pressure trends following intravitreal ranibizumab injections for neovascular age-related macular degeneration-the role of oral acetazolamide in protecting glaucoma patients.
    Murray CD; Wood D; Allgar V; Walters G; Gale RP
    Eye (Lond); 2014 Oct; 28(10):1218-22. PubMed ID: 25081290
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Single-Chain Antibody Fragment VEGF Inhibitor RTH258 for Neovascular Age-Related Macular Degeneration: A Randomized Controlled Study.
    Holz FG; Dugel PU; Weissgerber G; Hamilton R; Silva R; Bandello F; Larsen M; Weichselberger A; Wenzel A; Schmidt A; Escher D; Sararols L; Souied E
    Ophthalmology; 2016 May; 123(5):1080-9. PubMed ID: 26906165
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol.
    Berg K; Pedersen TR; Sandvik L; Bragadóttir R
    Ophthalmology; 2015 Jan; 122(1):146-52. PubMed ID: 25227499
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gray hyper-reflective subretinal exudative lesions in exudative age-related macular degeneration.
    Ores R; Puche N; Querques G; Blanco-Garavito R; Merle B; Coscas G; Oubraham H; Semoun O; Souied EH
    Am J Ophthalmol; 2014 Aug; 158(2):354-61. PubMed ID: 24794284
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk, Prevalence, and Progression of Glaucoma in Eyes With Age-Related Macular Degeneration Treated With Intravitreal Anti-Vascular Endothelial Growth Factor Injections.
    Shah SM; Boopathiraj N; Starr MR; Dalvin LA; AbouChehade J; Damento G; Garcia MD; Hodge DO; Bakri SJ; Sit AJ; Iezzi R
    Am J Ophthalmol; 2022 Nov; 243():98-108. PubMed ID: 35932820
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effect of intravitreal injections of ranibizumab and aflibercept on the retinal nerve fiber layer in patients with concomitant neovascular age-related macular degeneration and glaucoma].
    Rud'ko AS; Budzinskaya MV; Andreeva IV; Karpilova MA; Smirnova TV
    Vestn Oftalmol; 2019; 135(5. Vyp. 2):177-183. PubMed ID: 31691657
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bevacizumab for neovascular age-related macular degeneration using a treat-and-extend regimen: clinical and economic impact.
    Shienbaum G; Gupta OP; Fecarotta C; Patel AH; Kaiser RS; Regillo CD
    Am J Ophthalmol; 2012 Mar; 153(3):468-473.e1. PubMed ID: 21996309
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect on intraocular pressure in patients receiving unilateral intravitreal anti-vascular endothelial growth factor injections.
    Hoang QV; Mendonca LS; Della Torre KE; Jung JJ; Tsuang AJ; Freund KB
    Ophthalmology; 2012 Feb; 119(2):321-6. PubMed ID: 22054994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.